|
US3821201A
(en)
*
|
1971-08-09 |
1974-06-28 |
Merck & Co Inc |
Dibenzo(c,e)azepin-5-ones
|
|
US4463001A
(en)
|
1980-10-20 |
1984-07-31 |
Farmitalia Carlo Erba S.P.A. |
6-Substituted 6H-dibenzo[b,d]pyran derivatives and process for their preparation
|
|
JPH02304080A
(ja)
|
1989-05-17 |
1990-12-17 |
Toyo Pharma- Kk |
６Ｈ―ジベンゾ［ｂ，ｄ］ピラン―６―オン誘導体，その製法及び用途
|
|
EP0586608A1
(en)
|
1991-05-29 |
1994-03-16 |
Pfizer Inc. |
Tricyclic polyhydroxylic tyrosine kinase inhibitors
|
|
JPH05214334A
(ja)
|
1992-02-05 |
1993-08-24 |
Konica Corp |
有機薄膜エレクトロルミネッセンス素子
|
|
JPH06234753A
(ja)
|
1993-02-10 |
1994-08-23 |
Meiji Seika Kaisha Ltd |
イソオキサゾール化合物およびその塩
|
|
JPH07188215A
(ja)
|
1993-12-28 |
1995-07-25 |
Meiji Seika Kaisha Ltd |
アゾール誘導体及びその塩
|
|
JPH1172941A
(ja)
|
1997-08-29 |
1999-03-16 |
Canon Inc |
電子写真感光体
|
|
WO1999014217A1
(en)
|
1997-09-17 |
1999-03-25 |
Merck & Co., Inc. |
Aryloxymethyl carbapenem antibacterials
|
|
US6284753B2
(en)
|
1998-06-02 |
2001-09-04 |
Merck & Co., Inc. |
Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
|
|
HK1043788A1
(zh)
*
|
1999-05-04 |
2002-09-27 |
American Home Products Corporation |
四環黃體酮受體調節劑化合物及方法
|
|
AU2002215737A1
(en)
|
2000-12-05 |
2002-06-18 |
Chemokine Therapeutics Corporation |
Tricyclic therapeutics for chemokine mediated diseases
|
|
AU2002251949A1
(en)
|
2001-02-16 |
2002-09-04 |
Bristol-Myers Squibb Company |
Compounds having retinoid-like activity
|
|
WO2004073612A2
(en)
|
2003-02-13 |
2004-09-02 |
Merck & Co. Inc. |
Estrogen receptor modulators
|
|
EP1618101B1
(de)
*
|
2003-02-25 |
2017-12-20 |
Merck Patent GmbH |
Benzochromenderivate
|
|
US7365193B2
(en)
|
2004-02-04 |
2008-04-29 |
Abbott Laboratories |
Amino-substituted tricyclic derivatives and methods of use
|
|
EP1652841A1
(en)
|
2004-04-30 |
2006-05-03 |
Switch Biotech Aktiengesellschaft |
Novel phenantridine analogues and their use as inhibitors of hyperproliferation of T cells and/or keratinocytes
|
|
US20090203725A1
(en)
*
|
2005-12-21 |
2009-08-13 |
Cornelis Arjan Van Oeveren |
Androgen Receptor Modulator Compounds and Methods
|
|
BRPI0708318A2
(pt)
|
2006-02-28 |
2011-05-24 |
Paloma Pharmaceuticals, Inc. |
composições e uso de compostos para tratar doenças caracterizadas por proliferação celular e angiogênese
|
|
US20090118135A1
(en)
*
|
2007-06-08 |
2009-05-07 |
The Burnham Institute |
Methods and compounds for regulating apoptosis
|
|
EP2214670A2
(en)
|
2007-11-02 |
2010-08-11 |
Taiga Biotechnologies, Inc. |
Compounds for treating abnormal cellular proliferation
|
|
CN101654401B
(zh)
|
2008-08-18 |
2013-06-05 |
中国人民解放军军事医学科学院毒物药物研究所 |
不对称联苯类化合物、含有它的药物组合物及其用途
|
|
DE102009022309A1
(de)
|
2009-05-22 |
2010-11-25 |
Merck Patent Gmbh |
Flüssigkristallanzeige
|
|
JP5385686B2
(ja)
*
|
2009-06-05 |
2014-01-08 |
サントリーホールディングス株式会社 |
血小板凝集抑制剤
|
|
WO2011011721A2
(en)
|
2009-07-24 |
2011-01-27 |
Amazentis Sa |
Compounds, compositions and methods for protecting brain health in neurodegenerative disorders
|
|
JPWO2011093483A1
(ja)
|
2010-02-01 |
2013-06-06 |
国立大学法人 鹿児島大学 |
Ｃ型肝炎治療剤
|
|
JP6054301B2
(ja)
|
2010-12-23 |
2017-01-11 |
アマゼンティス エスアーＡｍａｚｅｎｔｉｓ Ｓａ |
ミトコンドリア機能向上と、神経変性疾患および認知障害治療とのための組成物および方法
|
|
KR20140003521A
(ko)
|
2010-12-30 |
2014-01-09 |
이난타 파마슈티칼스, 인코포레이티드 |
페난트리딘 매크로사이클릭 ｃ형 간염 세린 프로테아제 억제제
|
|
WO2012108455A1
(ja)
*
|
2011-02-09 |
2012-08-16 |
参天製薬株式会社 |
３－ヒドロキシ－６Ｈ－ベンゾ［ｃ］クロメン－６－オン誘導体およびその製造方法
|
|
EP2729007A1
(de)
|
2011-07-04 |
2014-05-14 |
Bayer Intellectual Property GmbH |
Verwendung substituierter isochinolinone, isochinolindione, isochinolintrione und dihydroisochinolinone oder jeweils deren salze als wirkstoffe gegen abiotischen pflanzenstress
|
|
WO2013041461A1
(en)
|
2011-09-22 |
2013-03-28 |
Msd Oss B.V. |
Fsh receptor antagonists
|
|
DK4233858T3
(da)
|
2012-06-27 |
2025-05-12 |
Amazentis Sa |
Forbedring af autofagi eller forøgelse af levetiden ved indgivelse af urolithiner eller forstadier til disse
|
|
JP2014139161A
(ja)
*
|
2012-12-20 |
2014-07-31 |
Santen Pharmaceut Co Ltd |
１，２−ジヒドロキノリン合成中間体の製造方法
|
|
WO2014111580A1
(en)
|
2013-01-18 |
2014-07-24 |
Procell Sprl |
Urolithin b for muscle growth
|
|
EP2958906A1
(en)
|
2013-02-21 |
2015-12-30 |
Nobel Ilaç Sanayii Ve Ticaret A.S. |
3-substituted-6h-benzo[c]chromen-6-ones and 3-substituted-7,8,9,10-tetrahydro-6h-benzo[c]chromen-6-ones against senile dementia
|
|
CN104231023B
(zh)
|
2013-06-06 |
2019-02-05 |
南京汇诚制药有限公司 |
三环稠杂环类核苷氨基磷酸酯化合物、其制备方法及应用
|
|
KR20160075766A
(ko)
|
2013-10-29 |
2016-06-29 |
메디비르 아베 |
퀴나졸린계 호흡기 세포융합 바이러스 억제제
|
|
EP3663287B1
(en)
|
2013-12-23 |
2023-09-20 |
Amazentis SA |
Process scale synthesis of urolithins
|
|
GB201323008D0
(en)
|
2013-12-24 |
2014-02-12 |
Amazentis As |
Compounds and uses thereof
|
|
CN103772228B
(zh)
|
2014-01-16 |
2016-01-20 |
华东理工大学 |
联苯双酰胺类化合物及其制备和用途
|
|
WO2015140799A1
(en)
|
2014-03-18 |
2015-09-24 |
Carmel-Haifa University Economic Corp. Ltd |
Methods for improving cognitive function via modulation of quinone reductase 2
|
|
WO2015154047A1
(en)
*
|
2014-04-03 |
2015-10-08 |
Restorgenex Corporation |
Novel methods
|
|
JP2016162983A
(ja)
|
2015-03-04 |
2016-09-05 |
ダイキン工業株式会社 |
エッチング処理用組成物及びエッチング処理方法
|
|
CN105085463B
(zh)
*
|
2015-08-25 |
2017-06-16 |
浙江医学高等专科学校 |
一种微波快速制备联芳基七元内酯的方法
|
|
GB201515387D0
(en)
|
2015-08-28 |
2015-10-14 |
Amazentis Sa |
Compositions
|
|
GB201515391D0
(en)
|
2015-08-28 |
2015-10-14 |
Amazentis Sa |
Compositions
|
|
AU2016375177B2
(en)
|
2015-12-24 |
2022-09-01 |
Amazentis Sa |
Compositions comprising nicotinamide riboside and a urolithin
|
|
WO2018073321A1
(en)
|
2016-10-18 |
2018-04-26 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Natural product derivatives for inhibiting cellular necroptosis, ferroptosis and oxytosis
|
|
WO2018119208A1
(en)
|
2016-12-22 |
2018-06-28 |
Global Blood Therapeutics, Inc. |
Histone methyltransferase inhibitors
|
|
CN106632214B
(zh)
|
2016-12-28 |
2019-01-25 |
西北大学 |
一种大麻酚类化合物的合成方法
|
|
CN108530480B
(zh)
|
2017-03-06 |
2022-06-28 |
中国科学院上海药物研究所 |
Gpr84受体拮抗剂及其应用
|
|
CN106928173B
(zh)
*
|
2017-03-07 |
2019-04-16 |
中国科学院新疆理化技术研究所 |
薰衣草中的酚酸类化合物及其制备方法和用途
|
|
JP7761372B2
(ja)
|
2017-03-08 |
2025-10-28 |
アマゼンティス エスアー |
対象におけるマイトファジーを改善するための方法
|
|
US20180256471A1
(en)
|
2017-03-08 |
2018-09-13 |
Amazentis Sa |
Skin Treatment Methods
|
|
US20180256538A1
(en)
*
|
2017-03-08 |
2018-09-13 |
Amazentis Sa |
Method for improving mitophagy in subjects
|
|
US12171755B2
(en)
|
2017-10-25 |
2024-12-24 |
Children's Medical Center Corporation |
PAPD5 inhibitors and methods of use thereof
|
|
CN109761902B
(zh)
|
2017-11-09 |
2022-06-10 |
四川大学 |
6-菲啶酮衍生物及其制备方法和用途
|
|
DE102017126343A1
(de)
|
2017-11-10 |
2019-05-16 |
Peri Gmbh |
Bewehrung von 3D-gedruckten Betonkörpern
|
|
AU2019227733B2
(en)
|
2018-02-27 |
2024-08-01 |
Amazentis Sa |
Process-scale synthesis of urolithin A
|
|
WO2019205854A1
(zh)
|
2018-04-27 |
2019-10-31 |
四川大学 |
一种10h-吩噻嗪类铁死亡抑制剂及其制备方法与用途
|
|
WO2019211294A1
(en)
|
2018-04-30 |
2019-11-07 |
Amazentis Sa |
Urolithin a as immune enhancer
|
|
CA3100335A1
(en)
*
|
2018-05-15 |
2019-11-21 |
University Of Louisville Research Foundation, Inc. |
Urolithin a and derivatives thereof for use in therapy
|
|
PL245399B1
(pl)
*
|
2018-11-29 |
2024-07-15 |
Univ Warszawski Medyczny |
Kompozycja farmaceutyczna zawierająca urolitynę A lub jej pochodną do zastosowania zewnętrznego miejscowego w leczeniu, hamowaniu i zapobieganiu chorobom skóry i błon śluzowych o podłożu zapalnym
|
|
WO2020124206A1
(en)
|
2018-12-18 |
2020-06-25 |
University Of Manitoba |
Metal complexes, methods of making the same, and uses thereof
|
|
GB201912107D0
(en)
|
2019-08-22 |
2019-10-09 |
Amazentis Sa |
Combination
|
|
GB201916046D0
(en)
|
2019-11-04 |
2019-12-18 |
Amazentis Sa |
Diagnostic method
|
|
CN110862368B
(zh)
*
|
2019-11-25 |
2021-06-15 |
浙江工业大学 |
一种苯并香豆素类化合物的光催化氧化合成方法
|
|
CN111072850B
(zh)
*
|
2019-12-18 |
2022-02-15 |
湖北大学 |
荧光分子单体及其制备方法、聚集诱导发光水凝胶及其制备方法和应用
|
|
CN112778140B
(zh)
|
2020-12-29 |
2023-01-03 |
宁波博雅聚力新材料科技有限公司 |
一种含芴二胺单体、聚酰亚胺薄膜及其制备方法和用途
|
|
CA3206062A1
(en)
|
2021-01-27 |
2022-08-04 |
Said Oumouch |
Urolithin derivatives and methods of use thereof
|
|
CN119948002A
(zh)
|
2022-07-27 |
2025-05-06 |
范徳利亚股份公司 |
尿石素衍生物和治疗用途
|
|
US20240139149A1
(en)
|
2022-07-27 |
2024-05-02 |
Vandria Sa |
Therapeutic uses of urolithin derivatives
|
|
EP4712958A2
(en)
|
2023-05-18 |
2026-03-25 |
Vandria SA |
Use of urolithin derivatives in the treatment of amyotrophic lateral sclerosis
|